APO-PACLITAXEL, PACLITAXEL APOTEX (Apotex Pty Ltd)
Product name
APO-PACLITAXEL, PACLITAXEL APOTEX
Sponsor
Date registered
Evaluation commenced
Decision date
Approval time
253 working days (255)
Active ingredients
paclitaxel
Registration type
New generic medicine
Indication
Metastatic Breast Cancer
Albumin-bound APO-PACLITAXEL, PACLITAXEL APOTEX (powder for injection) are indicated for the treatment of metastatic carcinoma of the breast after failure of anthracycline therapy.